|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/07/16 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/07/16 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 09/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 25/08/2016 | |
| Director/Board Member | 58 | 25/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | +11.60% | +58.61% | +164.79% | 1,097B | |
| +1.51% | +11.77% | +69.61% | +57.53% | 622B | |
| +0.38% | +10.56% | +39.49% | +90.88% | 449B | |
| -0.71% | +6.34% | +29.51% | +24.01% | 334B | |
| +1.52% | +6.84% | +43.48% | +28.77% | 294B | |
| +1.15% | +3.39% | +32.68% | +41.78% | 286B | |
| +1.46% | +3.87% | -27.29% | -41.85% | 213B | |
| +0.62% | +4.59% | +30.10% | +63.03% | 195B | |
| -1.21% | +1.17% | +14.15% | +66.20% | 157B | |
| Average | +0.25% | +6.79% | +32.26% | +55.02% | 405.19B | |
| Weighted average by Cap. | +0.33% | +8.72% | +43.76% | +82.13% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
